Novonesis (Novozymes) B
NSISBC
Kedudukan dalam Saham
#1131
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Harga Saham
$71.97
Modal Pasaran
$20.00B
Perubahan (1 hari)
2.66%
Perubahan (1 tahun)
13.50%
Negara
DK
Perdagangan Novonesis (Novozymes) B (NSISBC)
Kategori
Basic Materials
Nisbah P/S bagi Novonesis (Novozymes) B (NSISBC)
Nisbah P/S pada October 2026 TTM: 6.15
Menurut laporan kewangan dan harga saham terkini Novonesis (Novozymes) B, nisbah P/S semasa (TTM) ialah 6.15. Pada akhir 2024, nisbah P/S syarikat ialah 29.56.
Sejarah nisbah P/S untuk Novonesis (Novozymes) B dari 2013 hingga 2026
Nisbah P/S pada akhir setiap tahun
| Tahun | Nisbah P/S | Ubah |
|---|---|---|
| 2026 (TTM) | 6.15 | -84.88% |
| 2025 | 40.69 | 37.68% |
| 2024 | 29.56 | 418.90% |
| 2023 | 5.70 | 1.94% |
| 2022 | 5.59 | -44.05% |
| 2021 | 9.99 | 42.76% |
| 2020 | 6.99 | 7.66% |
| 2019 | 6.50 | 10.95% |
| 2018 | 5.86 | -19.27% |
| 2017 | 7.25 | 38.95% |
| 2016 | 5.22 | -28.57% |
| 2015 | 7.31 | 11.28% |
| 2014 | 6.57 | 6.16% |
| 2013 | 6.19 | 0.00% |
Nisbah P/S untuk syarikat atau pesaing yang serupa
| Syarikat | Nisbah P/S | Perbezaan Nisbah P/S | Negara |
|---|---|---|---|
| 6.56 | 6.61% |
GB
|
|
| 4.06 | -33.96% |
FR
|
|
| 3.42 | -44.35% |
US
|
|
| 4.79 | -22.07% |
US
|
|
| 5.35 | -13.05% |
US
|
